Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-01
2011-03-01
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235800, C514S275000, C544S122000, C544S295000, C544S331000
Reexamination Certificate
active
07897605
ABSTRACT:
The present invention relates to substituted pyrimidines of formula I, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders and/or viral disorders.
REFERENCES:
patent: 6531479 (2003-03-01), Wang et al.
patent: 6699854 (2004-03-01), Wang et al.
patent: 7262202 (2007-08-01), Fischer et al.
patent: 7432260 (2008-10-01), Wang et al.
patent: 2005/0282843 (2005-12-01), Wang et al.
patent: 2005/0288307 (2005-12-01), Wang et al.
patent: 2006/0241297 (2006-10-01), Wang et al.
patent: 2006/0264628 (2006-11-01), McInnes et al.
patent: 2007/0021419 (2007-01-01), Wang et al.
patent: 2007/0021452 (2007-01-01), Wang et al.
patent: 2007/0270442 (2007-11-01), Green et al.
patent: 2008/0125404 (2008-05-01), Benigni et al.
patent: WO-97/19065 (1997-05-01), None
patent: WO-01/72745 (2001-10-01), None
patent: WO-03/029248 (2003-04-01), None
Bosseray, A. et al., “What's new in vaccines against herpes simplex infections?”Pathol. Biol. (Paris), vol. 50(8):483-92 (2002).
Cotsarelis, George et al., “Towards a molecular understanding of hair loss and its treatment,”Trends in Molecular Medicine, vol. 7(7):293-301 (2001).
Damasio, Antonio R., “Alzheimer's Disease and Related Dementias,”Cecil Textbook of Medicine, 20th Edition, W.B. Saunders Company, J. Claude Bennett, Ed., vol. 2:1992-1996 (1996).
Douglas, R. Gordon Jr., “Introduction to Viral Diseases,”Cecil Textbook of Medicine, 20th Edition, W.B. Saunders Company, J. Claude Bennett, Ed., vol. 2:1739-1747 (1996).
Goff, Stephen P., “Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways,”The Journal of Gene Medicine, vol. 3:517-528 (2001).
Layzer, Robert B., “Degenerative Diseases of the Nervous System,”Cecil Textbook of Medicine, 20th Edition, W.B. Saunders Company, J. Claude Bennett, Ed., vol. 2:2050-2057 (1996).
Razonable, R.R. et al., “Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections,”Herpes, vol. 10(3):60-65 (2003).
Simone, Joseph V., “Introduction,”Cecil Textbook of Medicine, 20th Edition, W.B. Saunders Company, J. Claude Bennett, Ed., vol. 1:1004-1010 (1996).
Fischer Peter Martin
McInnes Campbell
Meades Christopher
O'Boyle Janice
Wang Shudong
Cyclacel Limited
Kanik Cynthia L.
Nelson Mullins Riley & Scarborough LLP
Rao Deepak
Trinque Brian C.
LandOfFree
Pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2751015